Horses and Humans Research Foundation (HHRF) is excited to announce Zoetis Inc. (Zoetis) as a continued sponsor. The partnership includes support for HHRF’s 2022 Conference About Research: Connect, Learn & Inspire, which will be held at Fieldstone Farm in Chagrin Falls, OH, Aug. 13–14, 2022.
“Our organizations share a common dedication to equine health—and through Zoetis’ support of our annual conference—we can advance horse care to support healthier, more fulfilling lives for both species,” said Molly Sweeney, HHRF Founder and Equine Welfare Committee Chair. “Zoetis’ support makes it possible to expand our research and global knowledge of horse-human interactions to benefit horses and their owners worldwide.”
Zoetis is an industry leader committed to providing equine health products and services across the continuum of care and throughout a horse’s life. As an innovator in the animal health field, Zoetis is recognized for offering trusted horse care products like Quest® Gel and Quest Plus Gel dewormers, Dormosedan® Gel (detomidine hydrochloride) oral sedative, Pro-Stride® APS, a regenerative medicine device, and the Core EQ Innovator® vaccine.
The Zoetis sponsorship of HHRF spotlights both organizations’ commitment to advancing horse health and welfare while also valuing the profound and supportive connection that people develop with these animals. Both companies are dedicated to bringing global recognition to the healing benefits of horse-human interactions and what it takes to help horses live healthy lives.
“Horses have proven invaluable in providing physical and emotional support that promotes healing and well-being to the multitudes,” said HHRF board member and Zoetis Senior Veterinarian Dr. Mark Crisman. “We are proud to support purpose-driven organizations like HHRF who are dedicated to supporting research studies that explore the connection between horses and humans.”
About Humans and Horses Research Foundation
Since its founding in 2005, Horses and Human Research Foundation (HHRF) has granted $655,000 to fund 14 rigorously selected research studies concerning the supportive connection between horses and humans. Twelve of the funded studies have been published in peer-reviewed academic journals and span topics related to equine-assisted therapy for patients with autism, cerebral palsy, as well as physical and occupational therapy. For more information, visit www.horsesandhumans.org.
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide, from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees.
The Zoetis Equine division is committed to providing horse care you can count on. Our team includes numerous equine veterinarians and other experts who are inspired daily by the opportunity and profound responsibility to support horses, the owners who love them and the equine veterinarians and other care team members who safeguard their well-being every day. Whether at the clinic or in the field, Zoetis is always by your side with a comprehensive, innovative portfolio of equine products and services at every step of a horse’s care and throughout the journey of a horse’s life. Visit zoetisequine.com to learn more.
IMPORTANT SAFETY INFORMATION: Do not use DORMOSEDAN GEL in horses with pre-existing atrioventricular (AV) or sinoatrial (SA) block, with severe coronary insufficiency, cerebrovascular disease, respiratory disease, or chronic renal failure. Do not use in anesthetized or sedated horses, or in conditions of shock, severe debilitation or stress due to extreme heat, cold, fatigue or high altitude. Do not use in horses intended for human consumption. Handle gel-dosing syringes with caution to avoid direct exposure to skin, eyes or mouth. See full Prescribing Information.
IMPORTANT SAFETY INFORMATION: Do not use Quest Gel or Quest Plus Gel in foals less than 6 months of age or in sick, debilitated and underweight horses. Do not use in other animal species, as severe adverse reactions, including fatalities in dogs, may result. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.